Bringing multiple micronutrient supplements to pregnant women in Takeo Province, Cambodia
Assessing Health System Readiness for Scaling Antenatal MMS in Cambodia: A Mixed-Methods Assessment
University of British Columbia · NCT07400796
This project will see if giving pregnant women in Takeo Province MMS (multiple micronutrient supplements) can be delivered effectively through local health centers.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 710 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University of British Columbia (other) |
| Locations | 1 site (Phnom Penh) |
| Trial ID | NCT07400796 on ClinicalTrials.gov |
What this trial studies
This observational project follows pregnant individuals in Takeo Province who receive antenatal MMS during a government pilot to inform potential national scale-up. The study uses the Intervention Scalability Assessment Tool (ISAT) to examine fidelity and adaptation, reach and acceptability, and delivery setting and workforce capacity. Data are collected from clinic records, participant phone follow-up, and implementation staff feedback during routine antenatal care visits. Findings will identify context-specific barriers and facilitators for integrating MMS into Cambodia's maternal health services.
Who should consider this trial
Good fit: Ideal participants are pregnant individuals aged 18 or older who have attended at least one antenatal care visit at a health center or hospital in Takeo Province, can provide a working phone number, and consent to participate.
Not a fit: Individuals with diagnosed anemia who require iron–folic acid instead of MMS, those without phone access, or those who withdraw consent are unlikely to benefit from this pilot.
Why it matters
Potential benefit: If successful, the project could help expand access to improved prenatal nutrition and reduce maternal and newborn complications linked to micronutrient deficiencies.
How similar studies have performed: Randomized trials and WHO guidance indicate MMS provides added benefits over iron–folic acid for maternal and neonatal outcomes, but large-scale health system implementation studies in low- and middle-income countries remain limited.
Eligibility criteria
Show full inclusion / exclusion criteria
For the cohort of pregnant individuals consuming MMS: Inclusion Criteria: * Current pregnant * At least 18 years of age * Have attended at least one ANC visit at a health center or hospital in Takeo during the study period * Can provide a functioning phone number for follow-up contact * Willingness to participate and provide consent Exclusion Criteria: * Individuals with diagnosed anemia who require iron and folic acid (IFA) supplementation instead of MMS * Individuals unable to communicate via telephone,;(3) individuals who withdraw consent at any point
Where this trial is running
Phnom Penh
- Takeo province — Phnom Penh, Cambodia (RECRUITING)
Study contacts
- Principal investigator: Crystal Karakochuk, PHD — University of British Columbia
- Study coordinator: Meng Sokchea Program Manager, Helen Keller International, MD
- Email: MSokchea@hki.org
- Phone: +855 023 213 217
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Anemia, Pregnancy, Micronutrients, Supplement, Health Systems, Supply Chain Vulnerabilities, Adherence, anemia